Linzess is meant to be used as a long-term treatment
doi: 10.1080/09546634.2020.1826392 Summary Keywords glucagon-like peptide-1, liraglutide, inflammatory diseases, immunomodulation, signal pathways Citation Chen J, Mei A, Wei Y, Li C, Qian H, Min X, Yang H, Dong L, Rao X and Zhong J (2022) GLP-1 receptor agonist as a modulator of innate immunity
3 g PAC for 14 days in older people led to a significant reduction of sulfur amino acids (Pujos-Guillot et al., 2012)
Enhanced Muscle Mass: The combination of Tesamorelin Ipamorelin peptide stack could significantly enhance muscle mass by stimulating growth hormone (GH) release and increasing insulin-like growth factor 1 (IGF-1) levels
Using a method known as "target trial emulation," they compared patients initiating GLP-1 drugs with those initiating sodium-glucose cotransporter-2 (SGLT2) inhibitors or dipeptidyl peptidase-4 (DPP4) inhibitors
2023;120(13):e2218246120